Loading stock data…
Ardent Health, Inc. (ARDT)
$10.91+0.15 (+1.39%)
Ardent Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Ardent Health, Inc. in the Healthcare sector is trading at $10.91 with a market capitalization of $1.5B. Wall Street consensus targets $12.77 (11 analysts), implying a +17.1% move over the next 12 months. The stock is currently 30% below its 52-week high of $15.48, remaining 14.5% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +17.1% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
| Total Revenue | $1.50B↓ | $1.65B↑ | $1.58B↓ | $1.61B↑ | $1.60B |
| Gross Profit | $580.73M↓ | $702.94M↑ | $623.90M↓ | $676.16M↑ | $671.89M |
| Operating Income | $67.09M↓ | $137.28M↑ | $16.46M↓ | $104.75M↑ | $80.91M |
| Net Income | $41.38M↓ | $72.95M↑ | -$23.48M↓ | $44.96M↑ | $39.85M |
Peer Comparison
JNJUNHPFE
Fundamentals
Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, or...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.54B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
19.84
Beta
Defensive asset. Lower volatility than the S&P 500.
0.70
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-
Volume
Today's trading volume
449,031
Recent News
Implied Volatility Surging for Ardent Health Stock Options
Investors need to pay close attention to ARDT stock based on the movements in the options market lately.
Ardent Health (ARDT) Q2 2026 Earnings Call Transcript
Surgical volumes declined, but operational savings helped offset revenue pressure.
Is Ardent Health (ARDT) Cheap On Lowered Guidance And Weaker Q2 Earnings?
Ardent Health earnings and guidance reset Ardent Health (ARDT) reported second quarter 2026 results on 4 August, with net income and earnings per share lower than a year earlier and full year earnings guidance reduced. The company paired this softer outlook with an update on its ongoing share buyback program, which has now retired more than 1.2% of outstanding shares. See our latest analysis for Ardent Health. Ardent Health shares have had a strong run in 2026, with a 33.68% year to date...
New Strong Sell Stocks for August 7th
ARDX, ARDT and GPRE have been added to the Zacks Rank #5 (Strong Sell) List on August 7th, 2026.
Ardent Health Inc (ARDT) (Q2 2026) Earnings Call Highlights: Raising Impact Program Savings ...
Ardent Health Inc (ARDT) boosts cost savings guidance and secures key payer contract renewal, but navigates broad-based volume declines and a cautious second-half outlook.